search
Back to results

Use of Hair to Diagnose Breast Cancer

Primary Purpose

Breast Cancer

Status
Unknown status
Phase
Phase 2
Locations
Australia
Study Type
Interventional
Intervention
Cutting scalp hair
Sponsored by
Fermiscan Ltd
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Breast Cancer focused on measuring x-ray diffraction, hair, breast cancer, synchrotron

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)Female

Inclusion Criteria:

  • Adult women (aged >20) who are undergoing mammography, and
  • Who are willing and able to provide informed consent; and
  • Who have usable scalp hair

Exclusion Criteria:

  • Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.

Sites / Locations

  • St George Private HospitalRecruiting

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
October 17, 2006
Last Updated
October 18, 2006
Sponsor
Fermiscan Ltd
search

1. Study Identification

Unique Protocol Identification Number
NCT00390377
Brief Title
Use of Hair to Diagnose Breast Cancer
Official Title
A Study to Evaluate a Test for the Diagnosis of Breast Cancer Using X-Ray Diffraction of Hair Fibres.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2006
Overall Recruitment Status
Unknown status
Study Start Date
October 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Fermiscan Ltd

4. Oversight

5. Study Description

Brief Summary
This study aims to perform x-ray diffraction analysis of blinded hair samples from women with a documented health status, to validate the previous findings of James et al who described that x-ray diffraction patterns of human hair can distinguish samples from healthy subjects from those of diseased subjects, specifically those suffering from breast cancer. The primary hypothesis is that x-ray diffraction of hair can be used to distinguish hair from patients with confirmed breast cancer from subjects without detectable breast cancer.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
x-ray diffraction, hair, breast cancer, synchrotron

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
Single
Allocation
Non-Randomized
Enrollment
240 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Cutting scalp hair

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Eligibility Criteria
Inclusion Criteria: Adult women (aged >20) who are undergoing mammography, and Who are willing and able to provide informed consent; and Who have usable scalp hair Exclusion Criteria: Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Peter W French, BSc, MSc, PhD
Phone
+61292454460
Email
pfrench@fermiscan.com.au
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ronald Shnier, MBBS, FRACR
Organizational Affiliation
Symbion Health
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Gary Corino, BSc
Organizational Affiliation
Fermiscan Ltd
Official's Role
Study Director
Facility Information:
Facility Name
St George Private Hospital
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2217
Country
Australia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ronald Shnier, MBBS, FRACR

12. IPD Sharing Statement

Citations:
PubMed Identifier
15645416
Citation
James V, Corino G, Robertson T, Dutton N, Halas D, Boyd A, Bentel J, Papadimitriou J. Early diagnosis of breast cancer by hair diffraction. Int J Cancer. 2005 May 10;114(6):969-72. doi: 10.1002/ijc.20824.
Results Reference
background
PubMed Identifier
10078527
Citation
James V, Kearsley J, Irving T, Amemiya Y, Cookson D. Using hair to screen for breast cancer. Nature. 1999 Mar 4;398(6722):33-4. doi: 10.1038/17949. No abstract available.
Results Reference
background
PubMed Identifier
11390537
Citation
Meyer P, James VJ. Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer. J Natl Cancer Inst. 2001 Jun 6;93(11):873-5. doi: 10.1093/jnci/93.11.873. No abstract available.
Results Reference
background
PubMed Identifier
12587913
Citation
James VJ. The traps and pitfalls inherent in the correlation of changes in the fibre diffraction pattern of hair with breast cancer. Phys Med Biol. 2003 Jan 21;48(2):L5-9; discussion L11-3. doi: 10.1088/0031-9155/48/2/101.
Results Reference
background
PubMed Identifier
1289498
Citation
Kimura M, Tanaka N, Kimura Y, Miyake K, Kitaura T, Fukuchi H. Pharmacokinetic interaction of zonisamide in rats. Effect of other antiepileptics on zonisamide. J Pharmacobiodyn. 1992 Nov;15(11):631-9. doi: 10.1248/bpb1978.15.631.
Results Reference
background
PubMed Identifier
12529353
Citation
James V. False-positive results in studies of changes in fiber diffraction of hair from patients with breast cancer may not be false. J Natl Cancer Inst. 2003 Jan 15;95(2):170-1. doi: 10.1093/jnci/95.2.170. No abstract available. Erratum In: J Natl Cancer Inst. 2003 Feb 19;95(4):334.
Results Reference
background

Learn more about this trial

Use of Hair to Diagnose Breast Cancer

We'll reach out to this number within 24 hrs